Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

cannabidiol

Cannabidiol reduces seizures by half in severe epilepsy, study suggests

April 19, 2017 Research and Development Lennox-Gastaut syndrome, cannabidiol

A new large-scale study from the American Academy of Neurology has suggested that cannabidiol, a molecule derived from cannabis without …
News

Frog mucus may offer protection against flu virus

April 19, 2017 Research and Development Flu virus, influenza virus

Fairy tales about kissing frogs may have been onto something after all, maybe not to acquire a prince but possibly …
News
nursing_home

Behavioural intervention reduces need for antipsychotics in dementia treatment

April 19, 2017 Research and Development antipsychotic, dementia

A new study has suggested that dementia patients may not require as high a dosage of antipsychotic medication that was …
News

Pfizer launches Healthcare Hub to support healthtech startups

April 19, 2017 Medical Communications, Research and Development HealthTech, Pfizer, healthcare

Pfizer has announced the launch of ‘Pfizer Healthcare Hub: London’, a project that aims to help startups, focusing on the …
News
shutterstock_57369385

How regulators and NGOs are bringing the threat of fake medicines to light

April 18, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Fake medicine, counterfeit medicine, fake drugs

If recent world events are anything to go by, there is a growing awareness that anything read on the internet …
Feature
shutterstock_212432119

Allergan and Novartis join forces to develop NASH combo therapy

April 18, 2017 Manufacturing and Production, Research and Development Allergan, Novartis, nash

Allergan and Novartis have announced a new partnership to conduct a clinical trial in the treatment area of non-alcoholic steatohepatitis …
News
12324594465_18434550d7_z

Circassia stumbles with allergy treatments at clinical trial stage, again

April 18, 2017 Manufacturing and Production, Research and Development, Sales and Marketing Circassia

Circassia has slumped at the Phase 2 clinical trial stage again, after its failure with a treatment for those with …
News
bandage

‘Smart bandages’ could offer real-time wound feedback

April 18, 2017 Manufacturing and Production, Research and Development, Sales and Marketing Swansea University, smart bandage

The problem with bandages is that often we do not know how well a wound has healed under them until …
News
virus-1812092_960_720

Rebiotix delivers a gut bug PUNCH in C. diff trial

April 13, 2017 Research and Development C diff, C. diff, Rebiotix, microbiome

Rebiotix is one a new breed of companies that aims to use the human body’s microbiome to treat illnesses and …
News
three_syringes

Antiparasitic drug repurposed for treatment of brain tumours

April 13, 2017 Research and Development Low-grade glioma, parasitic pinworms, tumour

Researchers from The Feinstein Institute for Medical Research’s Karches Center for Oncology Research has had a research breakthrough by taking …
News
guildford_mmb_03_university_of_surrey

New ‘supermolecule’ seeks and removes harmful pharmaceuticals from water

April 13, 2017 Research and Development university of surrey

Researchers at the University of Surrey have discovered a ‘supermolecule’ which they claim can seek harmful pharmaceuticals from water in …
News
23603925074_7b03e9049d_z

Love it or hate it – Vitamin B12 may give the brain a boost

April 13, 2017 Research and Development Marmite, anxiety, epilepsy

Trying to explain to someone outside of the UK or Australia and New Zealand what Marmite is can be a …
News
computer_and_doctor

UK heading towards GP crisis as 40% consider leaving

April 12, 2017 Medical Communications, Research and Development GPs, General Practice, Jeremy Hunt, NHS

The University of Exeter has conducted a survey looking into GP morale in the south-west of the UK, and the …
News
acute_leukemia-all

Discovery of predictive protein signature births new leukaemia treatment hopes

April 12, 2017 Research and Development leukaemia

Researchers have discovered a protein signature which has proven to be highly predictive of leukaemia and has given rise to …
News
fdaoutsideweb

FDA approves first and only tardive dyskinesia treatment

April 12, 2017 Research and Development, Sales and Marketing FDA, Neurocrine Biosciences, tardive dyskinesia

US patients suffering with tardive dyskinesia (TD) will see access to the first approved treatment in the country with the …
News
The Gateway to Local Adoption Series

Latest content

Ofichem brings all brands under single trading name

April 23, 2026

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026

Incyclix Bio announces new additions to the Board

April 22, 2026

Remedy Plan Therapeutics Appoints Jotin Marango as CFO and CBO

April 21, 2026